Coppell Advisory Solutions Corp’s Lineage Cell Therapeutics LCTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q1
Sell
-162
Closed -$190 690
2022
Q4
$190 Buy
+162
New +$190 ﹤0.01% 1118